Abstract:BackgroundRelease and insufficient removal of endogenous nucleic acids may be involved in triggering autoimmune reactions important in the initiation of systemic autoimmune diseases including rheumatoid arthritis (RA). Nucleic acid sensing molecules, such as the endosomal Toll-like receptors (TLRs) 7 and 9, have been linked to pathogenic autoimmune processes, but their role in RA is less clear. Data obtained in rats with pristane-induced arthritis (PIA) suggested involvement of TLR9 in the pathogenesis of this arthritis model1.ObjectivesTo gain more insight into the role of TLR9 in autoimmune arthritis, TLR9 inhibition with specific oligodeoxynucleotide sequences (ODN)2 was investigated in rats with PIA. To further investigate TLR9 involvement, streptococcal cell wall (SCW) arthritis was induced in TLR9-/- mice.MethodsArthritis was induced in mice with SCW lysates and in rats with the mineral oil pristane. Rats were treated with a TLR9 antagonist, starting before disease induction. Arthritis was scored using established scoring systems, inflammation and bone erosion were quantified by histological analysis. Levels of α−1-acid-glycoprotein (AGP), rheumatoid factor (RF) and IL-6 in sera were analysed. The role of TLR9 in osteoclast differentiation and activation was investigated in vitro.ResultsIn PIA, the TLR9 antagonist reduced arthritis severity by ~50%, which was accompanied by a reduction of AGP, IL-6 and RF. TLR9 inhibition led to reduced inflammation, bone erosion and cartilage degradation. Moreover, the T cell-dependent chronic phase of SCW arthritis was significantly suppressed in TLR9-/- mice. Remarkably, TLR7 and TLR9 mRNA levels strongly differed in the course of in vitro osteoclastogenesis. Whereas TLR7 expression did not change throughout osteoclastogenesis, expression of TLR9 was higher in precursor cells than in mature osteoclasts and stimulation with a TLR9 agonist (CpG) completely inhibited osteoclastogenesis.ConclusionsTaken together, the results suggest a role for TLR9 in the T cell-dependent phases of PIA and SCW arthritis thus an important involvement of the DNA (CpG) recognising TLR9 in the initiation of autoimmune arthritis and during osteoclastogenesis. The precise role(s) of TLR9 in the different stages of arthritis needs to be further elucidated in future experiments.References[1] Hoffmann MH, et al. Nucleic acid-stimulated antigen-presenting cells trigger T cells to induce disease in a rat transfer model of inflammatory arthritis. J Autoimmun, 2011;36(3–4):288–300. [2] Duramad O, et al. Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation. J Immunol, 2005;174(9):5193–200.Disclosure of InterestNone declared

Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice

Post-translational Modifications in T Cells in Systemic Erythematosus Lupus

TLR9 regulates the autophagy-lysosome pathway to promote dendritic cell maturation and activation by activating the TRAF6-cGAS-STING pathway

Impact of TLR9 on Hyper-Responsive ITAM Signaling in a Mouse Model of SLE (47.24)

Phosphatase PP2A is Essential for T H 17 Differentiation

A STAT3 palmitoylation cycle promotes TH17 differentiation and colitis

Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy

Tumor Progression Locus 2 Promotes Mouse Plasmacytoid Dendritic Cell Cytokine Secretion and Signaling

B cell autophagy mediates TLR7-dependent autoimmunity and inflammation

Tlr9-Induced Mir-155 And Ets-1 Decrease Expression Of Cd1d On B Cells In Sle

Palmitoylation Facilitates Inflammation Through Suppressing NOD2 Degradation Mediated by the Selective Autophagy Receptor SQSTM1.

P020 Toll-like Receptor 9 Influences Inflammatory Arthritis and Osteoclastogenesis

TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.

TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells

Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus

Palmitoylation Restricts SQSTM1/p62-mediated Autophagic Degradation of NOD2 to Modulate Inflammation

Blockade of TLR9 Signaling in B Cells Impaired Anti-Dsdna Antibody Production in Mice Induced by Activated Syngenic Lymphocyte-Derived DNA Immunization

Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation

Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity

Toll-like Receptor 9 is Correlated to Disease Activity in Chinese Systemic Lupus Erythematosus Population.

AB0040 Toll-like receptor 9 influences inflammatory arthritis and osteoclastogenesis